Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

about

Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.

P2860

Q50077469-FA46AA10-E0D2-4AE9-A6D2-9837E7E62D69

P2860

Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

Item

http://www.wikidata.org/entity/Q42257839

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@en

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@nl

type

Item

label

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@en

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@nl

prefLabel

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@en

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@nl

P1476

Safety of prophylactic intraca ...... with penetrating keratoplasty.

@en

P2093

Ceyhun Arici

http://www.w3.org/2001/XMLSchema#string

Erdogan Cicik

http://www.w3.org/2001/XMLSchema#string

Mustafa Unal

http://www.w3.org/2001/XMLSchema#string

Osman Sevki Arslan

http://www.w3.org/2001/XMLSchema#string

P2860

Acute endophthalmitis following cataract surgery: a systematic review of the literature.

The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001.

In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.

Toxic anterior segment syndrome.

Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.

Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery.

Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

Intracameral moxifloxacin: in vitro safety on human ocular cells.

Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.

Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.

P304

795-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3980/J.ISSN.2222-3959.2014.05.10

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eray Atalay

Mehmet Serhat Mangan

P577

2014-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25349795

http://www.w3.org/2001/XMLSchema#string

P932

4206883

http://www.w3.org/2001/XMLSchema#string

Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

about

P2860

P2860

Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932